Year in Review

Moderator(s)

• TL

  Theresa Lu, MD, PhD

  Hospital for Special Surgery
  NEW YORK, New York, United States

  Disclosure(s): Mestag Therapeutics: Advisor or Review Panel Member (Ongoing)
• 

  Elizabeth Volkmann, MD, MS

  Associate Professor, Division of Rheumatology
  University of California, Los Angeles
  Los Angeles, California, United States

  Disclosure(s): AbbVie/Abbott: Consultant (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Atyr Pharma: Grant/Research Support (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing), Grant/Research Support (Ongoing); Horizon: Grant/Research Support (Ongoing); Kadmon: Grant/Research Support (Ongoing); Prometheus: Grant/Research Support (Ongoing)

Session Coordinator(s)

• 

  Gregory Gardner, MD

  University of Washington
  Anacortes, WA, United States

  Disclosure information not submitted.

Year in Review is always one of the highlights of Convergence. This session provides an overview of the impactful literature published during the 12 months prior to Convergence. Drs. England and Davidson are leaders in clinical and basic science research of the rheumatic diseases and will provide attendees with a compelling overview of cutting-edge concepts in rheumatology.

Presentations:

• 8:00 AM – 8:30 AM Central Time

  Year in Review: Basic Science
  

  Speaker: Anne Davidson, MBBS, FRACP – Feinstein Institutes for Medical Research
• 8:30 AM – 9:00 AM Central Time

  Year in Review: Clinical Science
  

  Speaker: Bryant England, MD, PhD – University of Nebraska Medical Center